EYLER CHARLES R 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Dec 4, 2018
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2018-12-03$22.77/sh−1,239$28,212→ 33,967 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 13, 2017 to satisfy tax obligations in connection with the vesting of restricted stock units.